The American Cancer Society released updated guidelines for colorectal cancer screening, adding options for a blood-based ...
Medical Device Network on MSN
Labcorp announces colorectal cancer test availability in US
ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.
Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...
A major European trial has pushed colonoscopy back into the medical spotlight. After 13 years, the NordICC study found that ...
A new test could be an option for the 40% of Americans over age 45 who are not up to date with screenings. The Food and Drug Administration provided final approval on Monday for a new colorectal ...
There's been a steep increase in colon cancer cases among adults 45 to 49 in recent years, and that's a good thing, experts say. This upsurge means that more colon cancers are being caught at an ...
Tens of millions of middle-aged and older Americans haven't gotten their recommended checks for early signs of potential colon cancer, either through the "gold standard" of colonoscopy or a ...
Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...
Starting next month, Ontarians who are 45 years old will be eligible for colorectal cancer screening. Some patients and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results